Our motto, “The Remedy is Experience”, reflects the overall mission of our program.
The purpose of our postgraduate year one (PGY1) residency program is to develop accountability; practice patterns; habits; and expert knowledge, skills, attitudes, and abilities in pharmacy practice. These programs will build upon Doctor of Pharmacy (PharmD) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.
The purpose of our PGY2 programs is to build upon the broad-based competencies achieved in a PGY1 residency, deepening the resident's ability to provide care in the most complex of cases or in the support of care through practice leadership. Residents will have the opportunity to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and transforming both into improved medication therapy for patients. Upon completion of this program, the resident should possess the competencies that enable attainment of board certification and qualify for a career path in their respective specialty area.
The purpose of our postgraduate year one (PGY1) residency program is to develop accountability; practice patterns; habits; and expert knowledge, skills, attitudes, and abilities in pharmacy practice. These programs will build upon Doctor of Pharmacy (PharmD) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.
The purpose of our PGY2 programs is to build upon the broad-based competencies achieved in a PGY1 residency, deepening the resident's ability to provide care in the most complex of cases or in the support of care through practice leadership. Residents will have the opportunity to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and transforming both into improved medication therapy for patients. Upon completion of this program, the resident should possess the competencies that enable attainment of board certification and qualify for a career path in their respective specialty area.
FAQs
Q. When are applications due in PhorCas?
A. The application deadline for Phase 2 is March 28, 2022 11:59 PM EST
Q. When do the residency programs start?
A. The PGY1 start date is July 1, 2022 with mandatory paid orientation starting approximately two weeks prior. The PGY2 start date is July 6, 2022
Q. Did you early commit for any PGY2 programs this year?
A. NO; we have recruiting for ALL PGY2 positions. Infectious Diseases, Emergency Medicine and Ambulatory Care are still recruiting.
Residency Policy UpdatesNOTICE: New York State and hospital vaccination policies are subject to ongoing changes. Currently all hospital employees and vendors are mandated to be fully vaccinated for COVID-19 (including a booster dose, effective 1/31/2022) and wear an appropriate mask within the hospital. If you should match with our residency, you will be required to conform to the policy that is in place at the time the residency position begins.
| |||||||
| policy_r008_for_resident_involvement_in_pt_committee_2017.pdf |
| policy__r010_early_committment_2017.pdf |
| 20_-_policy_04__resident_duty_hours_5-2017.pdf |
| 13_-_policy_02_-_policy_attendance_-_illness_vacation_conference_2015.pdf |
Benefits Summary
| TBHC Benefits Summary PGY1 |
| TBHC Benefits Summary PGY2 |